Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea.

WS, Choi; JY, Noh; J, Lee; JY, Choi; JS, Lee; MS, Kim; HS, Kim; J, Bang; N, Lavis; WJ, Kim

doi:10.1080/21645515.2017.1381808

Public

Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18-60 years of age in the Republic of Korea.

Shared by NobleBlocks on Nov 17, 2017 • 12:00 AM UTC

Authors:

Choi WS

Noh JY

Lee J

Abstract

VaxigripTetra® (Sanofi Pasteur, Lyon, France) is a quadrivalent split-virion inactivated influenza vaccine (IIV4) containing two B-lineage strains approved in the European Union and Taiwan in 2016 for individuals ≥ 3 years of age. Here, we describe an observer-blind, randomized, controlled, multicen...

Subject

Adults

Inactivated Influenza Vaccine

Republic Of Korea

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!